Hound Partners’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-49,867
Closed -$498K 163
2021
Q3
$498K Hold
49,867
0.03% 178
2021
Q2
$501K Sell
49,867
-133
-0.3% -$1.34K 0.02% 220
2021
Q1
$493K Buy
+50,000
New +$493K 0.02% 233